Redwood Bioscience has named Peter Van Vlasselaer, PhD, executive chairman to Redwood's board of directors.  In this role, Vlasselaer will be actively guiding Redwood on drug and platform development as well as corporate strategy.  

Currently, Vlasselaer is the executive chairman of iPierian, where he was the interim CEO earlier this year.  He previously served as the founding CEO of Arresto Biosciences which was acquired by Gilead Sciences in December 2010.  

"We are very pleased to be able to access Peter's proven abilities in shepherding novel technologies from research into the clinic and driving value for investors," stated David Rabuka, co-founder, president & chief scientific officer.